{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:35:17Z","timestamp":1791297317152,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ygyno.2011.06.038","type":"journal-article","created":{"date-parts":[[2011,8,2]],"date-time":"2011-08-02T18:56:29Z","timestamp":1312311389000},"page":"200-204","source":"Crossref","is-referenced-by-count":133,"title":["Use of metformin and the risk of ovarian cancer: A case\u2013control analysis"],"prefix":"10.1016","volume":"123","author":[{"given":"Michael","family":"Bodmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan S.","family":"Jick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph R.","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2011.06.038_bb0005","first-page":"609","article-title":"Ovarian cancer: an overview","volume":"80","author":"Roett","year":"2009","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0010","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1023\/A:1020271000069","article-title":"Diabetes mellitus and ovarian cancer (Sweden)","volume":"13","author":"Weiderpass","year":"2002","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0015","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s00125-009-1440-6","article-title":"The influence of glucose-lowering therapies on cancer risk in type 2 diabetes","volume":"52","author":"Currie","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0020","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0025","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2337\/dc08-2175","article-title":"New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes","volume":"32","author":"Libby","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0030","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2337\/dc09-1380","article-title":"Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16","volume":"33","author":"Landman","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0035","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1200\/JCO.2009.19.6410","article-title":"Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer","volume":"27","author":"Jiralerspong","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0040","doi-asserted-by":"crossref","first-page":"s820","DOI":"10.1093\/ajcn\/86.3.820S","article-title":"Insulin, insulin-like growth factors, insulin resistance, and neoplasia","volume":"86","author":"Pollack","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0045","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1158\/0008-5472.CAN-06-1500","article-title":"Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells","volume":"66","author":"Zakikhani","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0050","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/1940-6207.CAPR-08-0081","article-title":"The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase","volume":"1","author":"Zakikhani","year":"2008","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0055","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ygyno.2008.04.008","article-title":"In vitro metformin anti-neoplastic activity in epithelial ovarian cancer","volume":"110","author":"Gotlieb","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0060","article-title":"Metformin attenuates ovarian cancer cell growth in an AMP- kinase dispensable manner","author":"Rattan","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0065","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1210\/en.2009-1429","article-title":"Phosphorylation and activation of AMP-activated protein kinase (AMPK) by metformin in the human ovary requires insulin","volume":"152","author":"Pellatt","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0070","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2165\/00002018-200427120-00004","article-title":"The general practice research database: role in pharmacovigilance","volume":"27","author":"Wood","year":"2004","journal-title":"Drug Saf"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0075","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1592\/phco.23.5.686.32205","article-title":"Validity of the general practice research database","volume":"23","author":"Jick","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0080","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/pubmed\/21.3.299","article-title":"Clinical information for research; the use of general practice databases","volume":"21","author":"Lawrenson","year":"1999","journal-title":"J Public Health Med"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0085","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jaad.2007.11.023","article-title":"Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: a population based case\u2013control study","volume":"58","author":"Brauchli","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0090","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1001\/archinte.168.8.820","article-title":"Use of thiazolidinediones and fracture risk","volume":"168","author":"Meier","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0095","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2337\/dc09-1791","article-title":"Long-term metformin use is associated with decreased risk of breast cancer","volume":"33","author":"Bodmer","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0100","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1158\/1055-9965.EPI-10-0940","article-title":"Metformin and the incidence of prostate cancer in patients with type 2 diabetes","volume":"20","author":"Azoulay","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0105","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/cncr.23275","article-title":"Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer","volume":"112","author":"Tworoger","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0110","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jama.2009.1052","article-title":"Hormone therapy and ovarian cancer","volume":"302","author":"Morch","year":"2009","journal-title":"Jama"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0115","doi-asserted-by":"crossref","unstructured":"Decensi A, Puntoni M, Goodwin P, et al. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res (Phila);3:1451\u201361.","DOI":"10.1158\/1940-6207.CAPR-10-0157"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0120","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1053\/j.gastro.2009.04.013","article-title":"Antidiabetic therapies affect risk of pancreatic cancer","volume":"137","author":"Li","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ygyno.2011.06.038_bb0125","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.bjc.6605593","article-title":"Are GPs under-investigating older patients presenting with symptoms of ovarian cancer? Observational study using General Practice Research Database","volume":"102","author":"Tate","year":"2010","journal-title":"Br J Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811005075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811005075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T17:51:42Z","timestamp":1560448302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811005075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0090825811005075"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.06.038","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}